Oasmia Pharmaceutical AB and Orion Corporation jointly agreed to end the agreement regarding distribution of Paclical® in the Nordic region. The cooperation is ended without any further obligations from either part. The distribution rights for the Nordic region returns to Oasmia and enhances flexibility regarding the European market.
For more information, please contact: Maria Lundén, Head of Public Relations, Oasmia Pharmaceutical AB.
E-mail: press@oasmia.com Phone: +46 (0) 18 50 54 40. German contacts: Dr. Sönke Knop, Peggy Kropmanns, edicto GmbH, Frankfurt, Germany. E-Mail: oasmia@edicto.de, Phone: +49 (0) 69 90 55 05 51. Information is also available at www.oasmia.com www.nasdaqomxnordic.com www.boerse-frankfurt.de
